You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CAR-macrophage

Showing 51 - 75 of 1,715
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large B-cell Lymphoma Trial in Hangzhou, Ningbo (CD19-7×19 CAR-T combined with Tislelizumab)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • CD19-7×19 CAR-T combined with Tislelizumab
  • Hangzhou, Zhejiang, China
  • +1 more
Dec 12, 2022

Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

Recruiting
  • Neoplasms
  • +2 more
  • RD13-02 cell infusion
  • Xuzhou, Jiangsu, China
    Affiliated hospital of Xuzhou medical college
Jun 7, 2023

Progestereone Induced Decidualization of Human Endometrial

Completed
  • Inflammatory Response
  • Abortion, Habitual
    • Tainan, Taiwan
      National Cheng-Kung University Hospital
    Oct 3, 2022

    Lymphoma, Non-Hodgkin Lymphoma, B-Cell Trial (BAFF CAR-T)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin Lymphoma, B-Cell
    • BAFF CAR-T
    • (no location specified)
    Aug 16, 2022

    Non-Hodgkin Lymphoma Trial in Aurora (CD19x22 CAR T Cells)

    Active, not recruiting
    • Non-Hodgkin Lymphoma
    • CD19x22 CAR T Cells
    • Aurora, Colorado
      University of Colorado Hospital
    Sep 1, 2022

    Neuromyelitis Optica Trial in Hangzhou (CD19 CAR-T cells injection)

    Recruiting
    • Neuromyelitis Optica
    • CD19 CAR-T cells injection
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Apr 12, 2023

    Immunotherapy, Multiple Myeloma Trial in Zhengzhou (Chimeric Antigen Receptor NK Cell Injection Targeting BCMA (BCMA CAR-NK))

    Recruiting
    • Immunotherapy
    • Multiple Myeloma
    • Chimeric Antigen Receptor NK Cell Injection Targeting BCMA (BCMA CAR-NK)
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Dec 14, 2022

    Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +5 more
    • CD19 specific Chimeric Antigen Receptor T Cell
    • Columbus, Ohio
      Nationwide Children's Hospital
    Mar 9, 2023

    Brain Gliomas Trial in Suzhou (Allogenic B7H3 CAR-?dT cell)

    Recruiting
    • Brain Gliomas
    • Allogenic B7H3 CAR-γδT cell
    • Suzhou, Jiangsu, China
      Dushu Lake Hospital Affiliated to Soochow University
    Aug 25, 2023

    Solid Tumor, Adult Trial in Beijing (CD70-targeting CAR-T cells)

    Recruiting
    • Solid Tumor, Adult
    • CD70-targeting CAR-T cells
    • Beijing, Iotherapeutic Department Of Chinsese PLA Gereral Hospital, China
      China
    Jul 8, 2023

    Lymphoma Trial in Beijing (CD70-targeting CAR-T cells)

    Recruiting
    • Lymphoma
    • CD70-targeting CAR-T cells
    • Beijing, Biotherapeutic Department Of Chinsese PLA Gereral Hospital, China
      China
    Jul 9, 2023

    Acute Myeloid Leukemia Trial in Beijing, Shenzhen, Haikou (CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells)

    Recruiting
    • Acute Myeloid Leukemia
    • CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells
    • Beijing, Beijing, China
    • +2 more
    Aug 8, 2023

    Multiple Myeloma Trial (BCMA CAR T cells, BCMA/CD19 CAR T cells)

    Enrolling by invitation
    • Multiple Myeloma
    • BCMA CAR T cells
    • BCMA/CD19 CAR T cells
    • London, County (optional), United Kingdom
      University College London Hospital
    Sep 15, 2022

    B Acute Lymphoblastic Leukemia Trial in Duarte (drug, procedure, other)

    Not yet recruiting
    • B Acute Lymphoblastic Leukemia
    • Autologous Anti-CD19 CAR-expressing T Lymphocytes
    • +6 more
    • Duarte, California
      City of Hope Medical Center
    Jan 30, 2023

    Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V Trial in Beijing (KRAS-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

    Recruiting
    • Solid Tumor, Adult
    • +4 more
    • KRAS-EphA-2-CAR-DC
    • +3 more
    • Beijing, Beijing, China
      Biotherapeutic Department of Chinsese PLA Gereral Hospital
    Nov 29, 2022

    Non-Hodgkin Lymphoma Trial in Columbus (Biospecimen Collection, Computed Tomography, Positron Emission Tomography)

    Recruiting
    • Non-Hodgkin Lymphoma
    • Biospecimen Collection
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Jan 13, 2023

    Solid Tumor, Adult, Lymphoma, EphA2 Overexpression Trial in Beijing (TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

    Recruiting
    • Solid Tumor, Adult
    • +6 more
    • TP53-EphA-2-CAR-DC
    • +3 more
    • Beijing, Beijing, China
      Biotherapeutic Department of Chinsese PLA Gereral Hospital
    Nov 29, 2022

    CAR, B Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Suzhou (ThisCART19A with Dose Level 1, ThisCART19A with Dose Level

    Recruiting
    • CAR
    • +2 more
    • ThisCART19A with Dose Level 1
    • ThisCART19A with Dose Level 2
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Jan 18, 2023

    Bradycardia, Heart Failure, Pacemaker-Induced Cardiomyopathy Trial in Novara (Left bundle branch area pacing (LBBAP), Right

    Recruiting
    • Bradycardia
    • +4 more
    • Left bundle branch area pacing (LBBAP)
    • Right ventricular pacing (RVP)
    • Novara, Italy
      Hospital "Maggiore della Carità", Division of Cardiology
    Jun 16, 2023

    Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

    Not yet recruiting
    • Follicular Lymphoma
    • +3 more
    • Tazemetostat Pill
    • New York, New York
      Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Jun 28, 2023

    Hematologic Malignancy, CAR-T Cell Therapy Trial in Boston (Educational Video Tool)

    Active, not recruiting
    • Hematologic Malignancy
    • CAR-T Cell Therapy
    • Educational Video Tool
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jan 24, 2023

    Relapsed Acute Myeloid Leukaemia Trial (Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL))

    Not yet recruiting
    • Relapsed Acute Myeloid Leukaemia
    • Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL)
    • (no location specified)
    Jul 4, 2023

    Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell

    Not yet recruiting
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • +5 more
    • Boston, Massachusetts
    • +1 more
    Jun 28, 2023

    CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

    Not yet recruiting
    • Lymphoma
    • Chimeric Antigen Receptor
    • (no location specified)
    Oct 24, 2023

    Pancreas Cancer, CAR-T Cell Therapy, Mesothelin Trial in Guangzhou (CAR-T cells)

    Recruiting
    • Pancreas Cancer
    • +3 more
    • CAR-T cells
    • Guangzhou, Guangdong, China
      The Second Affiliated Hospital of Guangzhou Medical University
    Mar 10, 2023